2023 Q2 Form 10-Q Financial Statement
#000162828023014756 Filed on May 02, 2023
Income Statement
Concept | 2023 Q2 | 2022 Q1 |
---|---|---|
Revenue | $466.7M | $401.6M |
YoY Change | 11.82% | 39.43% |
Cost Of Revenue | $322.3M | $268.3M |
YoY Change | 16.81% | 46.23% |
Gross Profit | $144.5M | $133.2M |
YoY Change | 2.09% | 27.5% |
Gross Profit Margin | 30.95% | 33.18% |
Selling, General & Admin | $126.4M | $86.53M |
YoY Change | 37.26% | 37.56% |
% of Gross Profit | 87.46% | 64.94% |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $13.54M | $9.743M |
YoY Change | 37.36% | 33.47% |
% of Gross Profit | 9.37% | 7.31% |
Operating Expenses | $126.4M | $86.53M |
YoY Change | 37.26% | 37.56% |
Operating Profit | $18.11M | $46.71M |
YoY Change | -63.38% | 12.29% |
Interest Expense | $11.95M | $1.231M |
YoY Change | 663.77% | 917.36% |
% of Operating Profit | 65.99% | 2.64% |
Other Income/Expense, Net | $357.0K | $84.00K |
YoY Change | 221.62% | -1.18% |
Pretax Income | $6.518M | $45.57M |
YoY Change | -86.42% | 9.49% |
Income Tax | $835.0K | $10.36M |
% Of Pretax Income | 12.81% | 22.73% |
Net Earnings | $5.683M | $35.21M |
YoY Change | -85.01% | 7.57% |
Net Earnings / Revenue | 1.22% | 8.77% |
Basic Earnings Per Share | $0.18 | $1.12 |
Diluted Earnings Per Share | $0.18 | $1.11 |
COMMON SHARES | ||
Basic Shares Outstanding | 31.44M shares | 31.50M |
Diluted Shares Outstanding | 31.54M shares | 31.60M |
Balance Sheet
Concept | 2023 Q2 | 2022 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $33.31M | $53.43M |
YoY Change | -35.91% | -67.93% |
Cash & Equivalents | $33.31M | $53.43M |
Short-Term Investments | ||
Other Short-Term Assets | $40.17M | $13.51M |
YoY Change | 48.98% | 37.83% |
Inventory | $686.9M | $565.2M |
Prepaid Expenses | ||
Receivables | $429.3M | $456.1M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $1.190B | $1.088B |
YoY Change | 5.19% | 12.58% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $151.5M | $116.2M |
YoY Change | 28.5% | -10.8% |
Goodwill | $443.3M | $198.1M |
YoY Change | 124.86% | |
Intangibles | $317.0M | $176.1M |
YoY Change | 83.6% | |
Long-Term Investments | ||
YoY Change | ||
Other Assets | $50.50M | $47.53M |
YoY Change | 10.32% | -8.43% |
Total Long-Term Assets | $1.071B | $636.1M |
YoY Change | 69.96% | 113.67% |
TOTAL ASSETS | ||
Total Short-Term Assets | $1.190B | $1.088B |
Total Long-Term Assets | $1.071B | $636.1M |
Total Assets | $2.261B | $1.724B |
YoY Change | 28.36% | 36.38% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $145.7M | $165.8M |
YoY Change | -28.39% | 39.95% |
Accrued Expenses | $233.3M | $257.4M |
YoY Change | 2.53% | 18.68% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $215.5M | $229.4M |
YoY Change | -6.06% | |
Long-Term Debt Due | $12.50M | |
YoY Change | ||
Total Short-Term Liabilities | $606.9M | $652.6M |
YoY Change | -8.09% | 94.57% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $479.4M | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $16.75M | $94.33M |
YoY Change | 227.32% | 128.4% |
Total Long-Term Liabilities | $496.2M | $94.33M |
YoY Change | 9596.85% | 128.4% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $606.9M | $652.6M |
Total Long-Term Liabilities | $496.2M | $94.33M |
Total Liabilities | $1.103B | $764.9M |
YoY Change | 65.77% | 101.03% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $961.6M | |
YoY Change | 5.65% | |
Common Stock | $90.73M | |
YoY Change | 9.97% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $1.049B | $959.4M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $2.261B | $1.724B |
YoY Change | 28.36% | 36.39% |
Cashflow Statement
Concept | 2023 Q2 | 2022 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $5.683M | $35.21M |
YoY Change | -85.01% | 7.57% |
Depreciation, Depletion And Amortization | $13.54M | $9.743M |
YoY Change | 37.36% | 33.47% |
Cash From Operating Activities | $26.21M | $23.21M |
YoY Change | 84.94% | 10.44% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $10.54M | $7.247M |
YoY Change | -219.02% | 16.76% |
Acquisitions | -$267.0K | -$595.0K |
YoY Change | ||
Other Investing Activities | $267.0K | $595.0K |
YoY Change | ||
Cash From Investing Activities | -$10.27M | -$6.652M |
YoY Change | 16.01% | 7.17% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | $3.125M | $0.00 |
YoY Change | ||
Cash From Financing Activities | -$28.66M | -21.96M |
YoY Change | 326.28% | 480.11% |
NET CHANGE | ||
Cash From Operating Activities | $26.21M | 23.21M |
Cash From Investing Activities | -$10.27M | -6.652M |
Cash From Financing Activities | -$28.66M | -21.96M |
Net Change In Cash | -$12.73M | -5.355M |
YoY Change | 805.84% | -148.56% |
FREE CASH FLOW | ||
Cash From Operating Activities | $26.21M | $23.21M |
Capital Expenditures | $10.54M | $7.247M |
Free Cash Flow | $15.67M | $15.97M |
YoY Change | -31.93% | 7.79% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q2 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000868780 | |
CY2023Q2 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q2 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q2 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q2 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q2 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q2 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q2 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q2 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-04-01 | |
CY2023Q2 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q2 | dei |
Entity File Number
EntityFileNumber
|
0-18914 | |
CY2023Q2 | dei |
Entity Registrant Name
EntityRegistrantName
|
Dorman Products, Inc. | |
CY2023Q2 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
PA | |
CY2023Q2 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
23-2078856 | |
CY2023Q2 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
3400 East Walnut Street | |
CY2023Q2 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Colmar | |
CY2023Q2 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
PA | |
CY2023Q2 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
18915 | |
CY2023Q2 | dei |
City Area Code
CityAreaCode
|
215 | |
CY2023Q2 | dei |
Local Phone Number
LocalPhoneNumber
|
997-1800 | |
CY2023Q2 | dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.01 per share | |
CY2023Q2 | dei |
Trading Symbol
TradingSymbol
|
DORM | |
CY2023Q2 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023Q2 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q2 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
CY2023Q2 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
CY2023Q2 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q2 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
31468334 | shares |
CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
466738000 | usd |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
401579000 | usd |
CY2023Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
322261000 | usd |
CY2022Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
268339000 | usd |
CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
144477000 | usd |
CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
133240000 | usd |
CY2023Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
126363000 | usd |
CY2022Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
86528000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
18114000 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
46712000 | usd |
CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
11953000 | usd |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
1231000 | usd |
CY2023Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
357000 | usd |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
84000 | usd |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
6518000 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
45565000 | usd |
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
835000 | usd |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
10358000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5683000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35207000 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
119000 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
1696000 | usd |
CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
5802000 | usd |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
36903000 | usd |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.18 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.12 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.18 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.11 | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31436000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31499000 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
31537000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
31601000 | shares |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
33307000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
46034000 | usd |
CY2023Q2 | dorm |
Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
|
1398000 | usd |
CY2022Q4 | dorm |
Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
|
1363000 | usd |
CY2023Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
429308000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
427385000 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
686949000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
755901000 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
40173000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
39800000 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
1189737000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1269120000 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
151541000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
148477000 | usd |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
108549000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
109977000 | usd |
CY2023Q2 | us-gaap |
Goodwill
Goodwill
|
443336000 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
443035000 | usd |
CY2023Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
316999000 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
322409000 | usd |
CY2023Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
50497000 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
48768000 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
2260659000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
2341786000 | usd |
CY2023Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
145686000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
179819000 | usd |
CY2023Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
14606000 | usd |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
19490000 | usd |
CY2023Q2 | dorm |
Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
|
170432000 | usd |
CY2022Q4 | dorm |
Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
|
192116000 | usd |
CY2023Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
215460000 | usd |
CY2022Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
239363000 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
12500000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
12500000 | usd |
CY2023Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
48239000 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
35007000 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
606923000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
678295000 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
479439000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
482464000 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
96571000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
98221000 | usd |
CY2023Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
16749000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
28349000 | usd |
CY2023Q2 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
11833000 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
11826000 | usd |
CY2023Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31469310 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31469310 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31430632 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31430632 | shares |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
315000 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
314000 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
90416000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
88750000 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
961597000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
956870000 | usd |
CY2023Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-3184000 | usd |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-3303000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1049144000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1042631000 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2260659000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2341786000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1042631000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1049000 | usd |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2312000 | usd |
CY2023Q2 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
433000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | usd |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
-2217000 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
119000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5683000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1049144000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
932736000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
0 | usd |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2152000 | usd |
CY2022Q1 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
10917000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
377000 | usd |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
-1851000 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1696000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35207000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
959400000 | usd |
CY2023Q2 | us-gaap |
Profit Loss
ProfitLoss
|
5683000 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
35207000 | usd |
CY2023Q2 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
13540000 | usd |
CY2022Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
9743000 | usd |
CY2023Q2 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
2744000 | usd |
CY2022Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
29000 | usd |
CY2023Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2334000 | usd |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2152000 | usd |
CY2023Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4673000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-16727000 | usd |
CY2023Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-68935000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
33034000 | usd |
CY2023Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
591000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
853000 | usd |
CY2023Q2 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
2130000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
1976000 | usd |
CY2023Q2 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-34258000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-12392000 | usd |
CY2023Q2 | dorm |
Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
|
-21683000 | usd |
CY2022Q1 | dorm |
Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
|
7202000 | usd |
CY2023Q2 | dorm |
Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
|
-3691000 | usd |
CY2022Q1 | dorm |
Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
|
409000 | usd |
CY2023Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
26210000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
23214000 | usd |
CY2023Q2 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-267000 | usd |
CY2022Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-595000 | usd |
CY2023Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
10537000 | usd |
CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7247000 | usd |
CY2023Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10270000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-6652000 | usd |
CY2023Q2 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
23900000 | usd |
CY2022Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
10000000 | usd |
CY2023Q2 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
3125000 | usd |
CY2022Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
0 | usd |
CY2023Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1049000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd |
CY2023Q2 | dorm |
Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
|
433000 | usd |
CY2022Q1 | dorm |
Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
|
10752000 | usd |
CY2023Q2 | dorm |
Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
|
-2254000 | usd |
CY2022Q1 | dorm |
Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
|
-1211000 | usd |
CY2023Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-28663000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-21963000 | usd |
CY2023Q2 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-4000 | usd |
CY2022Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
46000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-12727000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-5355000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
46034000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
58782000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
33307000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
53427000 | usd |
CY2023Q2 | us-gaap |
Interest Paid Net
InterestPaidNet
|
11534000 | usd |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
999000 | usd |
CY2023Q2 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1055000 | usd |
CY2022Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
712000 | usd |
CY2023Q2 | us-gaap |
Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
|
237700000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
|
275200000 | usd |
CY2023Q2 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
30839000 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
34267000 | usd |
CY2023Q2 | us-gaap |
Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
|
200491000 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
|
234871000 | usd |
CY2023Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
446544000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
478032000 | usd |
CY2023Q2 | us-gaap |
Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
|
9075000 | usd |
CY2022Q4 | us-gaap |
Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
|
8731000 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
686949000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
755901000 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
443035000 | usd |
CY2023Q2 | us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
233000 | usd |
CY2023Q2 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
68000 | usd |
CY2023Q2 | us-gaap |
Goodwill
Goodwill
|
443336000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
354517000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
37518000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
316999000 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
354517000 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
32108000 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
322409000 | usd |
CY2023Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5500000 | usd |
CY2022Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3000000 | usd |
CY2023Q2 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
|
100000000 | usd |
CY2023Q2 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
20500000 | usd |
CY2023Q2 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
500000 | usd |
CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
466738000 | usd |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
401579000 | usd |
CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
466738000 | usd |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
401579000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
238922 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
92.07 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
93944 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
98.02 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
59382 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
77.02 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
8392 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
81.56 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
265092 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
97.88 | |
CY2022Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
400000 | usd |
CY2023Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
400000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
268119 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
84.03 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
76784 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
91.28 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
1113 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
96.36 | |
CY2023Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
21702 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
72.85 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
322088 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
86.47 | |
CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M6D | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1935000 | usd |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
133913 | shares |
CY2023Q2 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
80.31 | |
CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y | |
CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1398000 | usd |
CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
237000 | shares |
CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27000 | shares |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5683000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35207000 | usd |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31436000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31499000 | shares |
CY2023Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
101000 | shares |
CY2022Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
102000 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
31537000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
31601000 | shares |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.18 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.12 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.18 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.11 | |
CY2023Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
3400000 | usd |
CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
2500000 | usd |